Dr. Thanh Ha Luu
Specialty: Obstetrics & Gynecology, Reproductive Endocrinology
Denver IVF & Fertility Center
3055 Roslyn Street
Denver, CO 80238
About Dr. Thanh Ha Luu
Dr. Thanh Ha Luu recently completed her OB-GYN residency at the Cleveland Clinic and has joined the Advanced Reproductive Medicine Department as a reproductive endocrinology and infertility fellow. She attended Swarthmore College where she earned a Bachelor of Arts in biochemistry and Japanese. She then attended Northwestern University as a Master of Public Policy and Administration (MPPA) program candidate before completing her medical degree at Rush Medical College in Chicago.
In her free time, Dr. Luu is a travel enthusiast and enjoys volunteering, biking, cooking and hiking. She is looking forward to working with patients and guiding them through the issues of infertility.
Fellowship, University of Colorado Denver, reproductive endocrinology & infertility (2018-present)
Residency, Cleveland Clinic (2014-2018)
MD, Rush Medical College (2014)
MPPA program candidate, Northwestern University (2008-2009)
BS, Swarthmore College, biochemistry and Japanese (2007)
Professional associations and affiliations
American Society for Reproductive Medicine
American College of Obstetrics and Gynecology
Society for Reproductive Endocrinology and Infertility
Research publications and abstracts - peer reviewed publications
Kim S, Luu TH, Llarena N, Falcone T. Role of robotic surgery in treating fibroids and benign uterine mass. Best Pract Res Clin Obstet Gyneaecol. 2017 Nov;45:48-59.
Soto, E, Luu, TH, Liu, X, Magrina, JF, Wasson, MN, Einarsson, JI, Cohen, SL, Falcone, T. “Laparoscopy vs robotic surgery for endometriosis (LAROSE): A multicenter randomized controlled trial.” Fertility and Sterility. 2017 Apr;107(4): 996-1002.
Luu, TH, Uy-Kroh, MJ. New Developments in Surgery for Endometriosis. Clinical Obstetrics and Gynecology. 2017 Jun;6(2):245-251.
Hickman LC, Kotlyar A, Luu TH, Falcone T. Do we need a robot in endometriosis surgery? Minerva Ginecol. 2016 Jun;68(3):380-7.
Nonzee NJ, Ragas DM, Ha Luu T, Phisuthikul AM, Tom L, Dong X, Simon MA. Delays in Cancer Care Among Low-Income Minorities Despite Access. J Women’s Health (Larchmt). 2015 Jun;24(6):506-14.
Raizer JJ, Fitzner KA, Jacobs DI, Bennett CL, Liebling DB, Luu TH, Trifilio SM, Grimm SA, Fisher MJ, Haleem MS, Ray PS, McKoy JM, DeBoer R, Tulas KM, Deeb M, McKoy JM. “Economics of Malignant Gliomas: A Critical Review.” J Oncol Pract. 2014 Dec 2.
Ragas DM, Nonzee NJ, Tom LS, Phisuthikul AM, Luu TH, Dong X, Simon MA. “What women want: patient recommendations for improving access to breast and cervical cancer screening and follow-up.” Women’s Health Issues. 2014 Sep-Oct;24(5):511-8
Simon MA, Nonzee NJ, McKoy JM, Liu D, Luu TH, Byer P, Eklund EA, Richey EA, Wu Z, Dong X, Rademaker AW. “Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study.” BMC Health Serv Res. 2013 Aug 15;13:314. doi: 10.1186/1472-6963-13-314.
Simon MA, Ragas DM, Nonzee NJ, Phisuthikul AM, Luu TH, Dong X. “Perceptions of Patient-Provider Communication in Breast and Cervical Cancer-Related Care: A Qualitative Study of Low-Income English- and Spanish-Speaking Women.” J Community Health. 2013 Aug;38(4):707-15.
Nonzee NJ, McKoy JM, Rademaker AW, Byer P, Luu TH, Liu D, Richey EA, Samaras AT, Panucci G, Dong X, Simon MA. “Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.” BMC Health Serv Res. 2012 Sep 25; 12:340.
Mayhew R, McKoy JM, Ha Luu T, Lopez I, Frick M, Bennett CL. “Adverse drug interactions: moving from perception to action.” Pharmacoeconomics. 2010; 28(1):19-22.
Zakarija, A, Kwaan, HC, Moake, JL, Banderanko, N, Pandey, DK, McKoy, JM, Yarnold, PR, Raisch, DW, Winters, JL, Raife, TJ, Cursio, JF, Luu, TH, Richey, EA, Fisher, MJ, Ortel, TL, Tallman, MS, Zheng, XL, Matsumoto, M, Fujimura, Y, Bennett, CL. “Ticlopidine-and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factors for TTP project.” Kidney International. 2009 Feb; (112):S20-4.
Richey, EA, Lyons, EA, Nebeker, JR, Shankaran, V, McKoy, JM, Luu, TH, Nonzee, N, Trifilio, S, Sartor, O, Benson, AB, Carson, KR, Edwards, BJ, Gilchrist-Scott, D, Kuzel, TM, Raisch, DW, Tallman, MS, West, DP, Hirschfeld, S, Grillo-Lopez, AJ, Bennett, CL. “Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?” J Clin Oncol. 2009 Sep 10;27(26):4398-405.
Shankaran,V, Luu,TH, Nonzee, N, Richey, EA, McKoy, JM, Zivin, JG, Ashford, A, Lantigua, R, Frucht, H, Scoppettone, M, Bennett, CL, Gorin, SS. “Costs and Cost-Effectiveness of a Health Care Provider-Directed Intervention to Promote Colorectal Cancer (CRC) Screening.” J Clin Oncol. 2009 Nov 10;27(32):5370-5.
Samaras, A, McKoy, JM, Boyle, S, Luu, TH, Bennett, CL. "Clopidogrel-associated TTP: the next chapter". Community Oncology, September 2008: 496-497.
Irizarry, LD, Luu, TH, McKoy, JM, Samaras, A, Fisher, MJ, Carias, E, Raisch, DW, Calhoun, E, Bennett, CL. Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action. Community Oncology, March 2009: 132-134.
T. Luu, T Falcone. Endometrioma: from pathogenesis to treatment. Fertility and Sterility, Vol 108, Issue 3, e389. Video presentation at the American Society for Reproductive Medicine, 73rd Congress, San Antonio, TX, 2017.
T. Luu, R. Flyckt, T. Falcone. Hormonal suppression after hysterectomy does not affect reoperation free survival rates. Fertility and Sterility, Vol 108, Issue 3, e203. Poster presentation at the American Society for Reproductive Medicine, 73rd Congress, San Antonio, TX, 2017.
T. Luu, E. Soto, X. Liu, T. Falcone. Cost value of laparoscopic vs robotic surgery for endometriosis. Fertil and Steril. Volume 106, Issue 3, Supplement, e1-e404. Poster presentation at the American Society for Reproductive Medicine, 72nd Congress, Salt Lake City, UT, 2016. e276
Soto, E, Luu, TH, Liu, X, Magrina, JF, Einarsson, JI, Falcone, T. Laparoscopy vs robotic surgery for endometriosis (LAROSE): A multicenter randomized controlled trial. Oral Presentation at the European Society of Human Reproduction and Embrology (ESHRE) 32nd Annual Meeting in Helsinki, Finland, 2016. Abstract # H16-0458.
Zakarija, A, Kwaan, HC, Banderanko, N, Pandey, DK, Cursio, JF, Weiss, IM, Luu, TH, Winters, JL, Ortel, TL, Raife, TJ, Sarode, R, Bennett, CL. “Distinct Clinical Syndromes are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.” Blood. Nov 2007; 110 (11): # 1320. Atlanta, Georgia.
Bennett, CL, Luu, TH, Zakarija, A, Bandarenko, N, Pandey, DK, Kwaan, HC, Cursio, JF, McKoy, JM, Buffie, C, Winters, JL, Ortel, TL, Sarode, R, Zheng, XL, Raife, TJ, Matsumoto, M, Fujimura, Y, Rock, G. “Clinical and outcomes findings for thrombotic thrombocytopenic purpura among 467 persons with severely versus non-severely deficient ADAMTS13 levels.” Blood. Nov 2007; 110 (11): #2088. Atlanta, Georgia.
Pandey, DK, Zakarija, A, Bandarenko, N, Cursio, J, Luu, TH, Winters, J, Sarode, R, Kiss, J, Bennett, CL. “Antiplatelet/Anticoagulant therapy and Risk of Thrombotic Thrombocytopenic Purpura (TTP): Surveillance, Epidemiology and Risk Factors for TTP (SERF-TTP) Study, 2002-2007.” Accepted as a plenary session at American Society for Apheresis (ASFA) 2008. Galveston, Texas.
Zakarija, A, Yarnold,P, Kwaan, HC, Pandey, DK, Bandarenko, N, Luu, TH, Cursio, J, Weiss, I, Richey, EA, Sarode, R, Winters, J, Bennett, CL. “Idiopathic TTP: Predictors of Relapse and Mortality from the SERF (Surveillance, Epidemiology and Risk Factors)-TTP Group.” Accepted to an oral presentation at the American Association of Blood Banks 2008. Bethesda, Maryland.
Luu, TH, Sartor, O, Dandade,N, Halabi, S, Bennett, CL. “Comparability of health related quality of life, treatment decision making, and treatment satisfaction after PSA recurrence among prostate cancer patients who receive hormone therapy (HT) versus observation (OBS): Results from the COMPARE registry.” Accepted as a poster presentation at the American Society of Clinical Oncology 2009. # 5131. Orlando, Florida.
Hamer, S, Nonzee, NJ, Simon, MA, Liu, D, McKoy, JM, Byer, PJ, Feinglass, J, Rademaker, A, Wilson, R, Luu, TH, Phisuthikul, A, Richey, EA, Calhoun, EA, Bennett, CL. “Defining the role of patient navigators for men with abnormal prostate cancer screening test result in an urban setting.” Poster presentation at the 2009 Annual American Society of Clinical Oncology Meeting. May 31, 2009. Orlando, Florida.